Latest Portfolio Expansion News

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

Heavy Rare Earths Limited has completed acquisition of full mineral rights at its Prospect Hill Tin Project, setting the stage for a maiden resource estimate at the promising South Ridge prospect. Concurrently, the company advances uranium exploration across South Australia while strengthening its board.

Morella Corporation’s September quarter report reveals significant progress in its diversified critical minerals portfolio, including new titanium-vanadium exposure and streamlined US lithium assets. The company is gearing up for drilling and resource definition in 2026, supported by strengthened funding.

Tivan Limited has made significant strides in its critical minerals portfolio, establishing a key joint venture, acquiring the Molyhil Project, raising $15 million, and commencing drilling at Sandover. These developments underscore its growing role in Australia’s strategic minerals sector.

Sheffield Resources achieved a record quarterly concentrate production at its Thunderbird mine but faces subdued zircon sales due to challenging market conditions in China, withholding December quarter guidance.

Australian Unity Limited has announced a $120 million equity raising through a pro rata entitlement offer and wholesale placement, underpinning its ongoing transformation and capital management strategy. The company also reported robust FY2025 financial results, highlighting significant revenue growth and improved profitability.

Fat Prophets Global Contrarian Fund has successfully closed its Share Purchase Plan, raising nearly $1 million from existing shareholders. The capital injection will see over 740,000 new shares issued at a modest discount.

Dateline Resources has completed its acquisition of 100% ownership of the Argos Strontium Project in California, the largest known U.S. strontium deposit, complementing its Colosseum Gold-REE project and aligning with national strategic priorities.

Carbonxt Group has successfully closed its non-renounceable pro-rata entitlement offer, issuing over 51 million Loyalty Options and raising approximately $514,000 to support its expansion plans.

Lion Selection Group Limited reported a robust $39.2 million net profit for the year ended July 2025, driven by strong mark-to-market gains and strategic investments in Australian mining companies. The company’s portfolio value nearly doubled, reflecting timely market moves and a focus on precious and base metals.

Bass Oil Limited reported a 55% increase in EBITDA for the first half of 2025 despite lower oil prices, while progressing key gas field developments to enter the Australian East Coast Gas Market.

LTR Pharma Limited (ASX, LTP) reported significant progress in FY25, advancing its novel intranasal treatments for erectile dysfunction and expanding its commercial footprint in Australia and the US. The company secured key partnerships and capital raises, positioning itself for regulatory milestones and global market entry.